# Prothya Biosolutions Belgium – FDA Inspection, Mar 16, 2018

Source: https://www.keypedia.com/records/fda_inspections/prothya-biosolutions-belgium/aec2c474-6f22-442d-a6c3-d8185dae3256
Source feed: FDA_Inspections

> FDA inspection 1049646 of Prothya Biosolutions Belgium, March 16, 2018. Classification: Voluntary Action Indicated (VAI). Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1049646
- Company Name: Prothya Biosolutions Belgium
- Inspection Date: 2018-03-16
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/mihaly-s-ligmond/2904ef70-a757-49c7-9ac4-a2c07ee36001)
- [Issuing Officer](https://www.keypedia.com/people/susan-m-jackson/2a4e01d1-8761-4d40-b493-69a4163473bb)

Company: https://www.keypedia.com/companies/prothya-biosolutions-belgium/14cc76aa-03ad-49c2-aec8-4af088fd986a

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
